期刊
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
卷 65, 期 43, 页码 9443-9452出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jafc.7b02965
关键词
Arctii Fructus; arctigenin; allergic inflammation; mast cells; MAPK
资金
- National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015R1C1A1A02036733, NRF-2016R1A2B2013921]
The Arctium lappa seeds (Arctii Fructus) and its major active compound, arctigenin (ARC), are known to have anticancer, antiobesity, antiosteoporosis, and anti-inflammatory activities. However, the effect of Arctii Fructus and ARC on mast cell-mediated allergic inflammation and its associated mechanism have not been elucidated. Therefore, we attempted to investigate the antiallergic activity of Arctii Fructus and ARC on mast cells and experimental mouse models. Arctii Fructus water extract (AFW) or ethanol extract (AFE) and ARC reduced the production of histamine and pro-inflammatory cytokines such as interleukin (IL)-1 beta, IL-6, IL-8, and TNF-alpha in mast cells. AFW, AFE, and ARC inhibited phosphorylation of MAPKs and NF-kappa B in activated mast cells. Moreover, IgE-mediated passive cutaneous anaphylaxis and compound 48/80-induced anaphylactic shock were suppressed by AFW, AFE, and ARC administration. These results suggest that Arctii Fructus and ARC are potential therapeutic agents against allergic inflammatory diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据